Navigation Links
Penn study on olfactory nerve cells shows why we smell better when we sniff

Unlike most of our sensory systems that detect only one type of stimuli, our sense of smell works double duty, detecting both chemical and mechanical stimuli to improve how we smell, according to University of Pennsylvania School of Medicine researchers in the March issue of Nature Neuroscience.

This finding, plus the fact that both types of stimuli produce reaction in olfactory nerve cells, which control how our brain perceives what we smell, explains why we sniff to smell something, and why our sense of smell is synchronized with inhaling.

"The driving force for such synchronization remained a mystery for more than 50 years," says senior author Minghong Ma, PhD, Assistant Professor of Neuroscience. "These results help us understand how the mammalian olfactory system encodes and decodes odor information in the environment."

Researchers tested two different types of stimulation on olfactory neurons in mice: chemical stimuli, such as those used in making perfumes that have almond-like and banana-like scents, and mechanical stimuli, that is pressure carried by air flow to the nostrils while breathing.

The group did this first by puffing a chemical stimulus into the nose. As expected, this produced a reaction in the olfactory neurons, the primary sensory neurons in the nose that perceive odors. Researchers then puffed a solution without the chemical stimuli into the mouse's nose. This also produced a similar, but smaller reaction in the olfactory neurons. By decreasing pressure of the non-odor solution, they also found that the reaction in the olfactory neurons was less, confirming that it was sensitive to mechanical stimulation.

When olfactory neurons respond to odor molecules, they transmit chemical energy into electrical signals, which then trigger a secondary molecular messenger cascade that generates electrical impulses to the brain, signaling that it is smelling something. The group discovered that chemical and me
'"/>

Source:University of Pennsylvania School of Medicine


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
(Date:12/13/2009)... discovered five genetic variants that are associated with the ... international consortium of 96 scientists from 63 centres in ... basis of lung diseases. , The new findings provide ... Obstructive Pulmonary Disease (COPD) and asthma. In the past ... the molecular pathways that affect the health of the ...
(Date:12/11/2009)... COLLINS, COWild Malus orientalis species of wild apples ... native to the Middle East and Central Asia. A ... M. orientalis varieties from Georgia and Armenia with ... the large population and establishes a core collection that ... the breeding and research communities. , To identify and ...
(Date:12/11/2009)... CLEVELAND Case Western Reserve University has granted ... Inc. regarding a portfolio of insulin analogs. The ... exercise its option to obtain an exclusive license ... , Cleveland-based Thermalin Diabetes is developing treatments that ... the $12 billion, rapidly growing insulin market. Insulin ...
Breaking Biology News(10 mins):New genes for lung disease discovered 2Understanding apples' ancestors 2Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Neural stem cell differentiation factor discovered 9064 1Neural stem cell differentiation factor discovered 9064 2First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 1First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 2First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 3First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 4Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 1Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 2
... The American Dietetic Association has released an updated ... enhanced foods can benefit a person,s health when consumed ... and urges continued efforts to educate the public on ... issue of the Journal of the American Dietetic ...
... MD, PhD is the inaugural recipient of the Richard King ... American College of Medical Genetics Foundation (ACMGF) to encourage ABMG ... quality research in Genetics in Medicine. Each year the editorial ... ABMG trainee who was either a first or corresponding author ...
... H. Holmes Pioneer Awards will be presented on April 3 ... The awards honor two recipients who have contributed to the ... will be presented to Lawrence Platt, MD, of the David ... Los Angeles, California. The basic science award will be presented ...
Other Biology News:ADA releases updated position statement on functional foods 2ADA releases updated position statement on functional foods 3Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine 2AIUM Presents 2009 Joseph H. Holmes Pioneer Awards 2
(Date:12/11/2009)... DIEGO, Dec. 11 Ambit Biosciences Corporation announced ... Texas M. D. Anderson Cancer Center of the first ... Monotherapy E fficacy) Phase 2 pivotal ... leukemia (AML). AC220 is a novel, orally available, ... designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... 10 Endologix, Inc. (Nasdaq: ELGX ... disorders, announced today that Dan Lemaitre, former President ... Board of Directors effective December 11, 2009. ... non-independent directors. ,, Franklin D. Brown, Chairman of ... Dan Lemaitre to the Endologix Board of Directors. ...
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4
... the Board -, MADISON, N.J., April 24 ... Robert Essner, 60, has decided to retire,from the Company ... position,of Chairman since January 2003 and served as Wyeth,s ... of Directors has elected,Bernard Poussot, Wyeth,s President and Chief ...
... N.J., April 24 Pharmasset, Inc.,(Nasdaq: VRUS ) ... Conference being held from April 30, 2008 to May ... Schaefer Price,Pharmasset,s Chief Executive Officer, will provide an overview ... Morgan Stanley,representatives on Wednesday, April 30, 2008 at 3:40 ...
... genetics,Inc. (Nasdaq: DCGN ) today announced that it will ... to be issued on Thursday, May 1,after the close of ... live,webcast of its conference call to discuss these results and ... noon GMT/1pm,British Summer Time., The webcast can be accessed ...
Other Biology Technology:Wyeth Chairman Robert Essner Announces June 27 Retirement 2Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 2
Recombinant Viral CCI/Fc Chimera, CF...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
... precipitation offers major advantages over other RNA precipitation ... protein or carbohydrates. It is the method of ... synthesis from RNA preparations. Note, LiCl precipitation may ... isolations. If the RNA is to be used ...
... The SlowFade Light Antifade Kit is ... photobleaching seen with fluorescent dyes. This formulation ... fluorescein AMCA and Cascade Blue fluorophores that ... (S-2828). This kit is available with the ...
Biology Products: